These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 25144771)

  • 21. Prophylactic efficacy of TcVac2 against Trypanosoma cruzi in mice.
    Gupta S; Garg NJ
    PLoS Negl Trop Dis; 2010 Aug; 4(8):e797. PubMed ID: 20706586
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Construction and characterization of a recombinant human adenovirus type 3 vector containing two foreign neutralizing epitopes in hexon.
    Xue C; Tian X; Li X; Zhou Z; Su X; Zhou R
    Virus Res; 2014 Apr; 183():67-74. PubMed ID: 24518297
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of CD8+ T cell-mediated protective immunity against Trypanosoma cruzi.
    Miyahira Y; Kobayashi S; Takeuchi T; Kamiyama T; Nara T; Nakajima-Shimada J; Aoki T
    Int Immunol; 1999 Feb; 11(2):133-41. PubMed ID: 10069411
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DNA-Based immunization with Trypanosoma cruzi complement regulatory protein elicits complement lytic antibodies and confers protection against Trypanosoma cruzi infection.
    Sepulveda P; Hontebeyrie M; Liegeard P; Mascilli A; Norris KA
    Infect Immun; 2000 Sep; 68(9):4986-91. PubMed ID: 10948115
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of a trans-sialidase-ISCOMATRIX subunit vaccine candidate to protect against experimental Chagas disease.
    Bontempi IA; Vicco MH; Cabrera G; Villar SR; González FB; Roggero EA; Ameloot P; Callewaert N; Pérez AR; Marcipar IS
    Vaccine; 2015 Mar; 33(10):1274-83. PubMed ID: 25625671
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protection against enterovirus 71 with neutralizing epitope incorporation within adenovirus type 3 hexon.
    Tian X; Su X; Li X; Li H; Li T; Zhou Z; Zhong T; Zhou R
    PLoS One; 2012; 7(7):e41381. PubMed ID: 22848478
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trypanosoma cruzi as an effective cancer antigen delivery vector.
    Junqueira C; Santos LI; Galvão-Filho B; Teixeira SM; Rodrigues FG; DaRocha WD; Chiari E; Jungbluth AA; Ritter G; Gnjatic S; Old LJ; Gazzinelli RT
    Proc Natl Acad Sci U S A; 2011 Dec; 108(49):19695-700. PubMed ID: 22114198
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protection of mice against Trypanosoma cruzi by immunization with paraflagellar rod proteins requires T cell, but not B cell, function.
    Miller MJ; Wrightsman RA; Stryker GA; Manning JE
    J Immunol; 1997 Jun; 158(11):5330-7. PubMed ID: 9164953
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunization with Tc52 or its amino terminal domain adjuvanted with c-di-AMP induces Th17+Th1 specific immune responses and confers protection against Trypanosoma cruzi.
    Matos MN; Cazorla SI; Schulze K; Ebensen T; Guzmán CA; Malchiodi EL
    PLoS Negl Trop Dis; 2017 Feb; 11(2):e0005300. PubMed ID: 28234897
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cruzipain and Its Physiological Inhibitor, Chagasin, as a DNA-Based Therapeutic Vaccine Against
    Cerny N; Bivona AE; Sanchez Alberti A; Trinitario SN; Morales C; Cardoso Landaburu A; Cazorla SI; Malchiodi EL
    Front Immunol; 2020; 11():565142. PubMed ID: 33162979
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Replacing adenoviral vector HVR1 with a malaria B cell epitope improves immunogenicity and circumvents preexisting immunity to adenovirus in mice.
    Shiratsuchi T; Rai U; Krause A; Worgall S; Tsuji M
    J Clin Invest; 2010 Oct; 120(10):3688-701. PubMed ID: 20811151
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trypanosoma cruzi paraflagellar rod proteins 2 and 3 contain immunodominant CD8(+) T-cell epitopes that are recognized by cytotoxic T cells from Chagas disease patients.
    Egui A; Thomas MC; Morell M; Marañón C; Carrilero B; Segovia M; Puerta CJ; Pinazo MJ; Rosas F; Gascón J; López MC
    Mol Immunol; 2012 Oct; 52(3-4):289-98. PubMed ID: 22750229
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immune responses to gp82 provide protection against mucosal Trypanosoma cruzi infection.
    Eickhoff CS; Giddings OK; Yoshida N; Hoft DF
    Mem Inst Oswaldo Cruz; 2010 Aug; 105(5):687-91. PubMed ID: 20835618
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TcVac1 vaccine delivery by intradermal electroporation enhances vaccine induced immune protection against Trypanosoma cruzi infection in mice.
    Hegazy-Hassan W; Zepeda-Escobar JA; Ochoa-García L; Contreras-Ortíz JME; Tenorio-Borroto E; Barbabosa-Pliego A; Aparicio-Burgos JE; Oros-Pantoja R; Rivas-Santiago B; Díaz-Albiter H; Garg NJ; Vázquez-Chagoyán JC
    Vaccine; 2019 Jan; 37(2):248-257. PubMed ID: 30497833
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunization with cDNA expressed by amastigotes of Trypanosoma cruzi elicits protective immune response against experimental infection.
    Boscardin SB; Kinoshita SS; Fujimura AE; Rodrigues MM
    Infect Immun; 2003 May; 71(5):2744-57. PubMed ID: 12704149
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trypanosoma cruzi calreticulin: a possible role in Chagas' disease autoimmunity.
    Ribeiro CH; López NC; Ramírez GA; Valck CE; Molina MC; Aguilar L; Rodríguez M; Maldonado I; Martínez R; González C; Troncoso R; Lavandero S; Gingras AR; Schwaeble W; Ferreira A
    Mol Immunol; 2009 Mar; 46(6):1092-9. PubMed ID: 19108895
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trypanosoma cruzi: immune response and functional heart damage induced in mice by the main linear B-cell epitope of parasite ribosomal P proteins.
    Motrán CC; Cerbán FM; Rivarola W; Iosa D; Vottero de Cima E
    Exp Parasitol; 1998 Mar; 88(3):223-30. PubMed ID: 9562426
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunological and pathological responses in BALB/c mice induced by genetic administration of Tc 13 Tul antigen of Trypanosoma cruzi.
    García GA; Arnaiz MR; Laucella SA; Esteva MI; Ainciart N; Riarte A; Garavaglia PA; Fichera LE; Ruiz AM
    Parasitology; 2006 Jun; 132(Pt 6):855-66. PubMed ID: 16478565
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral exposure to Trypanosoma cruzi elicits a systemic CD8⁺ T cell response and protection against heterotopic challenge.
    Collins MH; Craft JM; Bustamante JM; Tarleton RL
    Infect Immun; 2011 Aug; 79(8):3397-406. PubMed ID: 21628516
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative and qualitative features of heterologous virus-vector-induced antigen-specific CD8+ T cells against Trypanosoma cruzi infection.
    Takayama E; Ono T; Carnero E; Umemoto S; Yamaguchi Y; Kanayama A; Oguma T; Takashima Y; Tadakuma T; García-Sastre A; Miyahira Y
    Int J Parasitol; 2010 Nov; 40(13):1549-61. PubMed ID: 20620143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.